Skip to main content

Table 2 Comparison between groups at baseline (T0)

From: The effects of chemotherapy on resting energy expenditure, body composition, and cancer-related fatigue in women with breast cancer: a prospective cohort study

Parameter

Cancer (n = 20)

Mean ± SD

Controls (n = 36)

Mean ± SD

p-value

Age

55.30 ± 11.0

52.9 ± 5.4

0.188

BW

70.1 ± 5.9

70.4 ± 13.8

0.906

BH

168.5 ± 6.0

167.4 ± 6.4

0.546

BMI

24.9 ± 3.4

25.1 ± 4.3

0.904

 18.0 (n%)

0 (0%)

0 (0%)

-

18.0–24.9 (n%)

9 (45.0%)

(52.8%)

-

 ≥ 25.0 (n%)

11 (55.0%)

17 (47.2%)

-

Metabolic state (mREE/pREE)

16.4 ± 12.3

2.5 ± 7.0

 < 0.001*

Hyper (n%)

6 (50.0%)

7 (19.4%)

-

Normo (n%)

7 (42.9%)

28 (77.8%)

-

Hypo (n%)

1 (7.1%)

1 (2.8%)

-

  1. Legend: n, number of participants; mREE, measured resting energy expenditure; pREE, predicted resting energy expenditure; FFM, fat-free mass; BW, body weight; FM, fat mass; BH, body height; BMI, body mass index; hyper, hypermetabolism; hypo, hypometabolism; normo, normometabolism; significance
  2. *p < 0.05